Artiva Biotherapeutics(us:ARTV)

    10.41

    -6.30%

    Updated on 2024-12-23

    Open:10.98
    Close:10.41
    High:11.32
    Low:10.31
    Pre Close:11.11
    Volume:29566.00
    Amount:323537.69
    Turnover:0.12%
    Shares:24.29M
    MarketCap:252.85M

    About Artiva Biotherapeutics Company

    Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

    Company Name: Artiva Biotherapeutics
    Company Address: 5505 Morehouse Drive,Suite 100
    Employees: 81
    Fiscar Year: 12-31
    IPO Date: 2024-07-19
    CIK: 1817241

    View all SEC Filings

    About

    Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
    Address:5505 Morehouse Drive,Suite 100
    Website:http://www.artivabio.com

    Market Movers